News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CareFusion Corporation Hit by Another Warning for Its Alaris Infusion Pump


4/9/2013 8:42:19 AM

The U.K.'s healthcare regulatory agency issues an alert for CareFusion's Alaris insulin pump, following a slew of prior troubles for this product. CareFusion (NYSE:CFN) was the target of a a Medical Device Alert from the U.K.'s Medicines & Healthcare Products Regulatory Agency, adding to the list of recent issues with the Alaris infusion pump. The latest alert warned that the safety alarm on the infusion pump may not detect small air bubbles that pose a risk of embolism if transferred to the patient. The San Diego-based device maker issued a warning for the Alaris system in November of 2012 based on post-market surveillance of the system.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES